Antiviral Therapeutics in Pediatric Transplant Recipients.

ABSTRACT: Recipients of solid organ and hematopoietic stem cell transplantation undergo substantial immune suppression, placing them at risk for opportunistic viral infection. Few randomized controlled trials have been dedicated to the treatment of viral infections in children, and current practices are extrapolated from data generated from adult patients. Here we discuss the prevention and treatment of viral infections using available antiviral drugs, as well as novel agents that may provide benefit to pediatric patients in the future.

SUBMITTER: Otto WR 

PROVIDER: S-EPMC8900721 | biostudies-literature | 2022 Mar

REPOSITORIES: biostudies-literature